The Next Big Newsroom

Click to read more about our latest Memorandum of Understanding

From Trivima to Innoskin®, NBIL is all set to take the big leap of commercialisation. Click here to read about our journey

Pooja Venkatesh (Co-Founder of NBIL) sheds light on how the company is using its patented tech to build Innoskin®

In conversation with Alok M Anil, Co-Founder at NBIL and an active member of the World Economic Forum talks about NBIL and its future plans

Incubated at Bangalore Bioinnovation Centre,NBIL has developed India’d first completely customisable 3D Bioprinter, Trivima and is on its journey to launch Innoskin®

With the aim to develop cutting edge technologies and products, that can enhance the Product R&D, NBIL is one of the startups to be selected into the Merck Accelerator Program

Pooja Venkatesh (Co-Founder of NBIL) talks about the company’s journey in building India’s first customisable 3D Bioprinter (Trivima) and Innoskin® (3D Bioprinted Human Skin)

With a long term vision to build 3D Bioprinted tissues for clinical applications, NBIL founder, Pooja talks about Innoskin® HE and creating partnerships to enhance global adoption.

NBIL showcased its 3D Bioprinted scaffolds, 3D printing technology and pre-surgical models at Autodesk University’s flagship event at Bangalore

The founders of NBIL speak about the initial impetus provided by government grants in the development of its 3D bioprinting tech

NBIL selected amongst the top five additive manufacturing startups (out of 572 companies) globally